Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov 5;9(11):778.
doi: 10.3390/antibiotics9110778.

Candida auris: An Overview of How to Screen, Detect, Test and Control This Emerging Pathogen

Teresa Fasciana  1 , Andrea Cortegiani  2 , Mariachiara Ippolito  2 , Antonino Giarratano  2 , Orazia Di Quattro  3 , Dario Lipari  4 , Domenico Graceffa  4 , Anna Giammanco  1
Affiliations
Review

Candida auris: An Overview of How to Screen, Detect, Test and Control This Emerging Pathogen

Teresa Fasciana et al. Antibiotics (Basel). .

Abstract

The multidrug-resistant yeast Candida auris is associated with invasive infections in critically ill patients and has been isolated in different countries worldwide. Ease of spread, prolonged persistence in the environment and antifungal drug resistance pose a significant concern for the prevention of transmission and management of patients with C. auris infections. Early and correct identification of patients colonized with C. auris is critical in containing its spread. However, this may be complicated by C. auris strains being misidentified as other phylogenetically related pathogens. In this review, we offer a brief overview highlighting some of the critical aspects of sample collection, laboratory culture-dependent and independent identification and the susceptibility profile of C. auris.

Keywords: Candida auris; Candida auris identification; antifungal resistance testing; screening.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Screen, detect, test and control for control of diffusion of C. auris. * For patients with a strong hypothesis of C. auris infection, in the case of negative screens, sampling should be repeated within seven days and before discontinuing any infection prevention and control measures.
See this image and copyright information in PMC

References

    1. Satoh K., Makimura K., Hasumi Y., Nishiyama Y., Uchida K., Yamaguchi H. Candida aurissp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol. Immunol. 2009;53:41–44. doi: 10.1111/j.1348-0421.2008.00083.x. - DOI - PubMed
    1. Lee W.G., Shin J.H., Uh Y., Kang M.G., Kim S.H., Park K.H., Jang H.-C. First Three Reported Cases of Nosocomial Fungemia Caused by Candida auris. J. Clin. Microbiol. 2011;49:3139–3142. doi: 10.1128/JCM.00319-11. - DOI - PMC - PubMed
    1. Magobo R.E., Corcoran C., Seetharam S., Govender N.P. Candida auris–Associated Candidemia, South Africa. Emerg. Infect. Dis. 2014;20:1250–1251. doi: 10.3201/eid2007.131765. - DOI - PMC - PubMed
    1. Calvo B., Melo A.S., Perozo-Mena A., Hernandez M., Francisco E.C., Hagen F., Meis J.F., Colombo A.L. First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia. J. Infect. 2016;73:369–374. doi: 10.1016/j.jinf.2016.07.008. - DOI - PubMed
    1. Ruiz-Gaitán A., Moret A.M., Tasias-Pitarch M., Aleixandre-Lopez A.I., Martínez-Morel H., Calabuig E., Salavert-Lletí M., Ramirez P., Hontangas J.L.L., Hagen F., et al. An outbreak due to Candida auris with prolonged colonisation and candidaemia in a tertiary care European hospital. Mycoses. 2018;61:498–505. doi: 10.1111/myc.12781. - DOI - PubMed

LinkOut - more resources